Additionally, a fair amount of MYC‐regulated and nuclear factor‐kappa B pathway associated miRNAs was useful in differentiating between Burkitt lymphoma (BL) and DLBCL [4, 5]. The gene discussed is MYC; the disease is Burkitt lymphoma.